Helena Díaz-Cuervo

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

Susan Olender, Katherine K Perez, Alan S. Go et al. · Clinical Infectious Diseases · 2020 · 171 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality

Susan Olender, Theresa L. Walunas, Estebán Martínez et al. · Open Forum Infectious Diseases · 2021 · 45 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Cds1 Controls the Release of Cdc14-like Phosphatase Flp1 from the Nucleolus to Drive Full Activation of the Checkpoint Response to Replication Stress in Fission Yeast

Helena Díaz-Cuervo, Avelino Bueno · Molecular Biology of the Cell · 2008 · 40 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Evolution of major non‐HIV‐related comorbidities in HIV‐infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014

Antonella d’Arminio Monforte, Helena Díaz-Cuervo, Andrea De Luca et al. · HIV Medicine · 2018 · 35 citations · Full text

Education, Health Sciences, Clinical Epidemiology +16

Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens

Karam Mounzer, Laurence Brunet, Jennifer S Fusco et al. · Open Forum Infectious Diseases · 2022 · 34 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16